[go: up one dir, main page]

DE60025241D1 - HäMOPOIETINREZEPTOR-PROTEIN, NR12 - Google Patents

HäMOPOIETINREZEPTOR-PROTEIN, NR12

Info

Publication number
DE60025241D1
DE60025241D1 DE60025241T DE60025241T DE60025241D1 DE 60025241 D1 DE60025241 D1 DE 60025241D1 DE 60025241 T DE60025241 T DE 60025241T DE 60025241 T DE60025241 T DE 60025241T DE 60025241 D1 DE60025241 D1 DE 60025241D1
Authority
DE
Germany
Prior art keywords
receptor protein
hemopoietin receptor
hemopoietin
protein
receptor
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60025241T
Other languages
English (en)
Other versions
DE60025241T2 (de
Inventor
Masatsugu Maeda
Noriko Yaguchi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Chugai Pharmaceutical Co Ltd
Original Assignee
Chugai Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Chugai Pharmaceutical Co Ltd filed Critical Chugai Pharmaceutical Co Ltd
Application granted granted Critical
Publication of DE60025241D1 publication Critical patent/DE60025241D1/de
Publication of DE60025241T2 publication Critical patent/DE60025241T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K16/00Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C07K16/2866Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Toxicology (AREA)
  • Cell Biology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
DE60025241T 1999-09-27 2000-09-27 HäMOPOIETINREZEPTOR-PROTEIN, NR12 Expired - Lifetime DE60025241T2 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP27335899 1999-09-27
JP27335899 1999-09-27
JP2000240397 2000-08-03
JP2000240397 2000-08-03
PCT/JP2000/006654 WO2001023556A1 (en) 1999-09-27 2000-09-27 Novel hemopoietin receptor protein, nr12

Publications (2)

Publication Number Publication Date
DE60025241D1 true DE60025241D1 (de) 2006-02-02
DE60025241T2 DE60025241T2 (de) 2007-01-11

Family

ID=26550628

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60025241T Expired - Lifetime DE60025241T2 (de) 1999-09-27 2000-09-27 HäMOPOIETINREZEPTOR-PROTEIN, NR12

Country Status (6)

Country Link
US (9) US7045595B2 (de)
EP (1) EP1221482B1 (de)
AU (1) AU7445900A (de)
DE (1) DE60025241T2 (de)
ES (1) ES2254224T3 (de)
WO (1) WO2001023556A1 (de)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MXPA01012331A (es) * 1999-06-01 2002-07-30 Schering Corp Proteinas receptoras de mamiferos, reactivos y metodos relacionados.
ES2339843T3 (es) 1999-06-02 2010-05-26 Chugai Seiyaku Kabushiki Kaisha Proteina receptora de hematopoyetina novedosa, nr10.
AU2007202362B2 (en) * 1999-09-03 2011-06-23 Merck Sharp & Dohme Corp. Mammalian receptor proteins; related reagents and methods
EP1221482B1 (de) * 1999-09-27 2005-12-28 Chugai Seiyaku Kabushiki Kaisha HäMOPOIETINREZEPTOR-PROTEIN, NR12
PL209128B1 (pl) * 2000-05-10 2011-07-29 Schering Corp Białko receptora spokrewnionego z receptorami cytokin oraz związane z nim produkty, sposoby i zastosowania
US7422743B2 (en) 2000-05-10 2008-09-09 Schering Corporation Mammalian receptor protein DCRS5;methods of treatment
US20030059871A1 (en) * 2000-10-06 2003-03-27 Cosman David J. Hematopoietin receptors HPR1 and HPR2
CA2501786C (en) 2002-10-30 2015-02-17 Genentech, Inc. Inhibition of il-17 production
DE602004020610D1 (de) 2003-05-12 2009-05-28 Affymax Inc Neue, an den erythropoietinrezeptor bindende peptide
DE602004028725D1 (de) * 2003-05-12 2010-09-30 Affymax Inc Neue poly(ethylenglycol) modifizierte erythropoietinagonisten und deren verwendungen
US7919118B2 (en) 2003-05-12 2011-04-05 Affymax, Inc. Spacer moiety for poly (ethylene glycol) modified peptide based compounds
KR101227666B1 (ko) * 2003-05-12 2013-01-31 아피맥스, 인크. 에리스로포이에틴 수용체에 결합하는 펩티드
CN101142234A (zh) * 2004-11-11 2008-03-12 阿费麦克斯公司 结合红细胞生成素受体的新肽
WO2006062685A2 (en) * 2004-11-11 2006-06-15 Affymax, Inc. Novel peptides that bind to the erythropoietin receptor
US20060257935A1 (en) * 2005-04-26 2006-11-16 Ajinomoto Co., Inc. Hematopoietic factor production promoter
US7550433B2 (en) * 2005-06-03 2009-06-23 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US7919461B2 (en) 2005-06-03 2011-04-05 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
US8324159B2 (en) * 2005-06-03 2012-12-04 Affymax, Inc. Erythropoietin receptor peptide formulations and uses
WO2007142325A1 (ja) 2006-06-08 2007-12-13 Chugai Seiyaku Kabushiki Kaisha 炎症性疾患の予防または治療剤
EP2118127A4 (de) * 2007-01-31 2010-12-01 Affymax Inc Linker auf stickstoffbasis zur bindung modifizierender gruppen an polypeptide und andere makromoleküle
JP5337055B2 (ja) 2007-02-28 2013-11-06 メルク・シャープ・アンド・ドーム・コーポレーション 免疫性障害の処置のための組合せ治療
NZ579251A (en) * 2007-02-28 2012-06-29 Schering Corp Engineered anti-il-23r antibodies
EP2288621A4 (de) * 2007-07-06 2012-01-04 Valorisation Hsj Soc En Commandite Il23-rezeptor-antagonisten und ihre verwendung
MX2010006097A (es) 2007-12-05 2010-08-04 Chugai Pharmaceutical Co Ltd Agentes terapeuticos para tratar el prurito.
US20090317400A1 (en) 2008-05-05 2009-12-24 Krzysztof Masternak Anti-IL 17A/IL-17F Cross-Reactive Antibodies and Methods of Use Thereof
WO2010027767A1 (en) * 2008-08-27 2010-03-11 Schering Corporation Engineered anti-il-23r antibodies
RU2605318C2 (ru) 2009-05-05 2016-12-20 Новиммун С.А. Анти-il-17f антитела и способы их применения
CN102206667B (zh) * 2011-04-18 2012-10-10 中国药科大学 重组质粒pET32a-hIL-23R-CHR及其构建表达
RU2749512C2 (ru) 2015-04-14 2021-06-11 Чугаи Сейяку Кабусики Кайся Фармацевтическая композиция для профилактики и/или лечения атопического дерматита, включающая антагонист ил-31 в качестве активного ингредиента
KR102514173B1 (ko) 2015-04-14 2023-03-27 추가이 세이야쿠 가부시키가이샤 Il-31 안타고니스트를 유효 성분으로서 함유하는 아토피성 피부염의 예방용 및/또는 치료용 의약 조성물
EP3232000A1 (de) 2016-04-15 2017-10-18 Siemens Aktiengesellschaft Plattform einer laufschaufel mit filmkühlungsöffnungen an der plattform und zugehörige strömugsmaschine
WO2021100794A1 (ja) 2019-11-20 2021-05-27 中外製薬株式会社 抗体含有製剤

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4732863A (en) * 1984-12-31 1988-03-22 University Of New Mexico PEG-modified antibody with reduced affinity for cell surface Fc receptors
JP2898064B2 (ja) 1989-08-03 1999-05-31 忠三 岸本 ヒトgp130蛋白質
GB9016440D0 (en) 1990-07-26 1990-09-12 Elopak Systems A laminate
US5783672A (en) 1994-05-26 1998-07-21 Immunex Corporation Receptor for oncostatin M
AUPN481295A0 (en) * 1995-08-16 1995-09-07 Medvet Science Pty. Ltd. Agonists of haemopoietic growth factors
AUPN564195A0 (en) * 1995-09-26 1995-10-19 Walter And Eliza Hall Institute Of Medical Research, The A novel haemopoietin receptor and genetic sequences encoding same
ES2334408T3 (es) * 1995-10-23 2010-03-09 Zenyth Operations Pty Ltd Receptor de hematopoyetina y secuencias geneticas que lo codifican.
US6642360B2 (en) 1997-12-03 2003-11-04 Genentech, Inc. Secreted polypeptides that stimulate release of proteoglycans from cartilage
US6747137B1 (en) 1998-02-13 2004-06-08 Genome Therapeutics Corporation Nucleic acid sequences relating to Candida albicans for diagnostics and therapeutics
CA2330547A1 (en) * 1998-06-24 1999-12-29 Chugai Research Institute For Molecular Medicine, Inc. Novel hemopoietin receptor proteins
US20030082734A1 (en) * 1999-06-01 2003-05-01 Dowling Lynette M. Mammalian receptor proteins; related reagents and methods
MXPA01012331A (es) * 1999-06-01 2002-07-30 Schering Corp Proteinas receptoras de mamiferos, reactivos y metodos relacionados.
ES2339843T3 (es) * 1999-06-02 2010-05-26 Chugai Seiyaku Kabushiki Kaisha Proteina receptora de hematopoyetina novedosa, nr10.
EP1221482B1 (de) 1999-09-27 2005-12-28 Chugai Seiyaku Kabushiki Kaisha HäMOPOIETINREZEPTOR-PROTEIN, NR12
PL209128B1 (pl) * 2000-05-10 2011-07-29 Schering Corp Białko receptora spokrewnionego z receptorami cytokin oraz związane z nim produkty, sposoby i zastosowania
JP2004501628A (ja) 2000-06-26 2004-01-22 ザイモジェネティクス,インコーポレイティド サイトカイン受容体zcytor17
US20030059871A1 (en) 2000-10-06 2003-03-27 Cosman David J. Hematopoietin receptors HPR1 and HPR2
WO2002077230A1 (fr) 2001-03-26 2002-10-03 Chugai Seiyaku Kabushiki Kaisha Variants d'epissage nr10
US7494804B2 (en) 2002-01-18 2009-02-24 Zymogenetics, Inc. Polynucleotide encoding cytokine receptor zcytor17 multimer
AU2003225525B2 (en) 2002-01-18 2008-07-24 Zymogenetics, Inc. Novel cytokine zcytor17 ligand
EP2110434A1 (de) 2002-02-25 2009-10-21 Genentech, Inc. Typ-1 Cytokine Rezeptor GLM-R
UA85996C2 (ru) 2002-05-01 2009-03-25 Шеринг Акциенгезельшафт Слитый антикоагулянтный белок тромбомодулина, который обеспечивает направленное перенесение к тканевому фактору
US7579000B2 (en) 2002-05-01 2009-08-25 Bayer Schering Pharma Ag Tissue factor targeted antibodies as anticoagulants
EP1671642A1 (de) 2004-12-15 2006-06-21 Universite D'angers Zusammensetzungen mit (Ant)agonisten von Oncostatin M (OSM), IL-31 und IFN-gamma zur Modulierung der Migration und Funktion von Keratinozyten via einen Rezeptor welcher OSMRbeta als Untereinheit enthält, und entprechende Anwendungen
US20060228329A1 (en) 2005-01-28 2006-10-12 Brady Lowell J Homogeneous preparations of IL-31
EP1856150A2 (de) 2005-02-14 2007-11-21 ZymoGenetics, Inc. Verfahren zur behandlung von durch positive dermale lymphozyten-antigen-zellen hervorgerufene krankheiten
US20060182743A1 (en) * 2005-02-14 2006-08-17 Janine Bilsborough Methods of treating skin disorders using an IL-31RA antagonist
ES2561628T3 (es) 2005-05-06 2016-02-29 Zymogenetics, Inc. Anticuerpos monoclonales IL-31 y métodos de uso
CA2633439A1 (en) 2006-01-10 2007-11-22 Zymogenetics, Inc. Methods of treating pain and inflammation in neuronal tissue using il-31ra and osmrb antagonists
WO2007142325A1 (ja) 2006-06-08 2007-12-13 Chugai Seiyaku Kabushiki Kaisha 炎症性疾患の予防または治療剤
TWI434703B (zh) * 2007-05-14 2014-04-21 Kao Corp 皮膚洗淨劑組成物
JP5132292B2 (ja) * 2007-12-07 2013-01-30 キヤノン株式会社 情報処理装置および情報処理方法

Also Published As

Publication number Publication date
ES2254224T3 (es) 2006-06-16
DE60025241T2 (de) 2007-01-11
US20060106201A1 (en) 2006-05-18
EP1221482A4 (de) 2003-03-26
US20090023660A1 (en) 2009-01-22
US7893205B2 (en) 2011-02-22
US20070203328A1 (en) 2007-08-30
WO2001023556A1 (en) 2001-04-05
US20090105459A1 (en) 2009-04-23
US20030009018A1 (en) 2003-01-09
US20090111972A1 (en) 2009-04-30
EP1221482A1 (de) 2002-07-10
US20090029484A1 (en) 2009-01-29
EP1221482B1 (de) 2005-12-28
US7893201B2 (en) 2011-02-22
US20090105458A1 (en) 2009-04-23
US7045595B2 (en) 2006-05-16
AU7445900A (en) 2001-04-30
US20090105457A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
DE60025241D1 (de) HäMOPOIETINREZEPTOR-PROTEIN, NR12
DE50007846D1 (de) Dreschkorb
DE60001530D1 (de) Verbinder
DE60006630D1 (de) Verbinder
MA25499A1 (fr) Contacteur-disjoncteur.
DE60008069D1 (de) Verbinder
MA26849A1 (fr) 4-pyridinyle-n-acyl-l-phenylalanines.
DE60001032D1 (de) Verbinder
EP1023437A4 (de) Rezeptorkinase,bin1
NO20013997L (no) Reseptoranalyse
DE60001783D1 (de) Verbinder
IT1310460B1 (it) Dispositivo gommatore .
DE60024400D1 (de) Empfangsgerät
ITBO990359A0 (it) Elettromandrino .
DE60029755D1 (de) Congawandschutz.
DE60003993D1 (de) Verbinder
ATE264301T1 (de) Muscarin-antagonisten
NO20021295D0 (no) Nikotinsyreacetylcholin-reseptor
ITBO990358A0 (it) Elettromandrino .
DE60009806D1 (de) Verbinder
FI991256A0 (fi) Apulaite tarjoilua varten
ATE314472T1 (de) Hämopoietinrezeptor-protein, nr12
ES1044367Y (es) Piñata mejorada.
ES1044838Y (es) Friegasuelos.
ITSS990004V0 (it) Piramide - ricordo.

Legal Events

Date Code Title Description
8332 No legal effect for de
8370 Indication of lapse of patent is to be deleted
8364 No opposition during term of opposition